Negative p53/positive p21 immunostaining is a predictor of favorable response to chemotherapy in patients with locally advanced bladder cancer.

Jpn J Cancer Res · 2000 · PMC5926463 · PMID 10804290

Europe PMC DOI

hedged sentences

0.0760

closest p · 1.5× alpha

0.0830

boldest claim

The sentences

showed a trendP=0.076so close (0.05 < p ≤ 0.1)

The good responders also showed a trend for longer cause-specific and progres- sion-free survival periods (P=0.076 and 0.094, respec- tively).

also in 53,322 other papers

a strong trendP=0.083so close (0.05 < p ≤ 0.1)

Both patients of the positive p53/negative p21 group showed NC while 24% of patients of the negative p53 and/or positive p21 groups showed NC; the positive p53/negative p21 group had a strong trend for NC com- pared to the negative p53 and/or positive p21 groups (P=0.083).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.